Position in AXGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$33,527
+$3,710 QoQ
Shares Held
1,012
+11.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026MCF Advisors LLC holds $2,195,041 across 21 Medical Devices names. AXGN ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
8,318 | $854,009 | |
| 2 | SYK |
Stryker Corp
|
1,432 | $470,540 | |
| 3 | MDT |
Medtronic plc
|
3,829 | $331,782 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
2,729 | $194,250 | |
| 5 | AORT |
Artivion, Inc.
|
1,204 | $44,090 | |
| 6 | BSX |
Boston Scientific Corp
|
675 | $42,356 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
380 | $34,359 | |
| 8 | AXGN |
Axogen, Inc.
This page
|
1,012 | $33,527 |
All Filings in AXGN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,527 | 1,012 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $29,817 | 911 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||